Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003157997> ?p ?o ?g. }
- W2003157997 endingPage "864" @default.
- W2003157997 startingPage "852" @default.
- W2003157997 abstract "Background. In metastatic colorectal cancer, mutation testing for KRAS exon 2 is widely implemented to select patients with wild-type tumors for treatment with the monocloncal anti-EGFR antibodies cetuximab and panitumumab. The added predictive value of additional biomarkers in the RAS-RAF-MAPK and PI3K-AKT-mTOR pathways in colorectal cancer is uncertain, which led us to systematically review the impact of alterations in KRAS (outside of exon 2), NRAS, BRAF, PIK3CA and PTEN in relation to the clinical benefit from anti-EGFR treatment.Methods. In total, 22 studies that include 2395 patients formed the basis for a meta-analysis on alterations in KRAS exons 3 and 4, NRAS, BRAF, and PIK3CA and PTEN and outcome of anti-EGFR treatment. Odds ratios for objective response rate (ORR) and hazard ratios (HR) for progression-free survival (PFS) and overall survival (OS) were calculated.Results. Mutations in KRAS exons 3 and 4, BRAF, PIK3CA and non-functional PTEN (mutations or loss of protein expression) significantly predicted poor ORR (OR = 0.26, OR = 0.29, OR = 0.39, and OR = 0.41, respectively). Significantly shorter PFS applied to mutations in KRAS exons 3 and 4 (HR = 2.19), NRAS (HR = 2.30) and BRAF (HR = 2.95) and non-functional PTEN (HR = 1.88). Significantly shorter OS applied to mutations in KRAS exons 3 and 4 (HR = 1.78), NRAS (HR = 1.85), BRAF (HR = 2.52), PIK3CA (HR = 1.43) and alterations in PTEN (HR = 2.09).Conclusions. Meta-analysis suggests that mutations in KRAS exons 3 and 4, NRAS, BRAF and PIK3CA and non-functional PTEN predict resistance to anti-EGFR therapies and demonstrates that biomarker analysis beyond KRAS exon 2 should be implemented for prediction of clinical benefit from anti-EGFR antibodies in metastatic colorectal cancer." @default.
- W2003157997 created "2016-06-24" @default.
- W2003157997 creator A5021232216 @default.
- W2003157997 creator A5023072692 @default.
- W2003157997 creator A5072521749 @default.
- W2003157997 creator A5077955066 @default.
- W2003157997 creator A5080534412 @default.
- W2003157997 date "2014-03-25" @default.
- W2003157997 modified "2023-10-01" @default.
- W2003157997 title "The predictive value of<i>KRAS, NRAS, BRAF, PIK3CA</i>and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis" @default.
- W2003157997 cites W1503485936 @default.
- W2003157997 cites W1997476308 @default.
- W2003157997 cites W2006491592 @default.
- W2003157997 cites W2008666806 @default.
- W2003157997 cites W2036045525 @default.
- W2003157997 cites W2038386885 @default.
- W2003157997 cites W2058273943 @default.
- W2003157997 cites W2067337678 @default.
- W2003157997 cites W2068216731 @default.
- W2003157997 cites W2070210483 @default.
- W2003157997 cites W2074404879 @default.
- W2003157997 cites W2085633477 @default.
- W2003157997 cites W2097709626 @default.
- W2003157997 cites W2098354753 @default.
- W2003157997 cites W2100589633 @default.
- W2003157997 cites W2104580737 @default.
- W2003157997 cites W2114048774 @default.
- W2003157997 cites W2125229905 @default.
- W2003157997 cites W2125592514 @default.
- W2003157997 cites W2128059540 @default.
- W2003157997 cites W2134142320 @default.
- W2003157997 cites W2134519717 @default.
- W2003157997 cites W2135672185 @default.
- W2003157997 cites W2138970634 @default.
- W2003157997 cites W2142564546 @default.
- W2003157997 cites W2143501159 @default.
- W2003157997 cites W2144897519 @default.
- W2003157997 cites W2149782431 @default.
- W2003157997 cites W2152490158 @default.
- W2003157997 cites W2157824687 @default.
- W2003157997 cites W2159187753 @default.
- W2003157997 cites W2161817637 @default.
- W2003157997 cites W2162160904 @default.
- W2003157997 cites W2167539263 @default.
- W2003157997 cites W2603058911 @default.
- W2003157997 doi "https://doi.org/10.3109/0284186x.2014.895036" @default.
- W2003157997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24666267" @default.
- W2003157997 hasPublicationYear "2014" @default.
- W2003157997 type Work @default.
- W2003157997 sameAs 2003157997 @default.
- W2003157997 citedByCount "306" @default.
- W2003157997 countsByYear W20031579972014 @default.
- W2003157997 countsByYear W20031579972015 @default.
- W2003157997 countsByYear W20031579972016 @default.
- W2003157997 countsByYear W20031579972017 @default.
- W2003157997 countsByYear W20031579972018 @default.
- W2003157997 countsByYear W20031579972019 @default.
- W2003157997 countsByYear W20031579972020 @default.
- W2003157997 countsByYear W20031579972021 @default.
- W2003157997 countsByYear W20031579972022 @default.
- W2003157997 countsByYear W20031579972023 @default.
- W2003157997 crossrefType "journal-article" @default.
- W2003157997 hasAuthorship W2003157997A5021232216 @default.
- W2003157997 hasAuthorship W2003157997A5023072692 @default.
- W2003157997 hasAuthorship W2003157997A5072521749 @default.
- W2003157997 hasAuthorship W2003157997A5077955066 @default.
- W2003157997 hasAuthorship W2003157997A5080534412 @default.
- W2003157997 hasBestOaLocation W20031579971 @default.
- W2003157997 hasConcept C104317684 @default.
- W2003157997 hasConcept C121608353 @default.
- W2003157997 hasConcept C126322002 @default.
- W2003157997 hasConcept C143998085 @default.
- W2003157997 hasConcept C207103383 @default.
- W2003157997 hasConcept C21790070 @default.
- W2003157997 hasConcept C2777609662 @default.
- W2003157997 hasConcept C2778332735 @default.
- W2003157997 hasConcept C2779998722 @default.
- W2003157997 hasConcept C2781187634 @default.
- W2003157997 hasConcept C36823959 @default.
- W2003157997 hasConcept C44249647 @default.
- W2003157997 hasConcept C502942594 @default.
- W2003157997 hasConcept C526805850 @default.
- W2003157997 hasConcept C54355233 @default.
- W2003157997 hasConcept C62478195 @default.
- W2003157997 hasConcept C71924100 @default.
- W2003157997 hasConcept C86554907 @default.
- W2003157997 hasConcept C86803240 @default.
- W2003157997 hasConceptScore W2003157997C104317684 @default.
- W2003157997 hasConceptScore W2003157997C121608353 @default.
- W2003157997 hasConceptScore W2003157997C126322002 @default.
- W2003157997 hasConceptScore W2003157997C143998085 @default.
- W2003157997 hasConceptScore W2003157997C207103383 @default.
- W2003157997 hasConceptScore W2003157997C21790070 @default.
- W2003157997 hasConceptScore W2003157997C2777609662 @default.
- W2003157997 hasConceptScore W2003157997C2778332735 @default.
- W2003157997 hasConceptScore W2003157997C2779998722 @default.
- W2003157997 hasConceptScore W2003157997C2781187634 @default.
- W2003157997 hasConceptScore W2003157997C36823959 @default.